title: Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice.
abstract: Here, we investigate the effects of endothelial nitric oxide synthase (eNOS) on angiogenesis, neurogenesis, neurotrophic factor expression, and neurological functional outcome after stroke. Wild-type and eNOS knock-out (eNOS-/-) mice were subjected to permanent occlusion of the right middle cerebral artery. eNOS-/- mice exhibited more severe neurological functional deficit after stroke than wild-type mice. Decreased subventricular zone (SVZ) progenitor cell proliferation and migration, measured using bromodeoxyuridine, Ki-67, nestin, and doublecortin immunostaining in the ischemic brain, and decreased angiogenesis, as demonstrated by reduced endothelial cell proliferation, vessel perimeter, and vascular density in the ischemic border, were evident in eNOS-/- mice compared with wild-type mice. eNOS-deficient mice also exhibited a reduced response to vascular endothelial growth factor (VEGF)-induced angiogenesis in a corneal assay. ELISAs showed that eNOS-/- mice have decreased brain-derived neurotrophic factor (BDNF) expression but not VEGF and basic fibroblast growth factor in the ischemic brain compared with wild-type mice. In addition, cultured SVZ neurosphere formation, proliferation, telomerase activity, and neurite outgrowth but not cell viability from eNOS-/- mice were significantly reduced compared with wild-type mice. BDNF treatment of SVZ cells derived from eNOS-/- mice restored the decreased neurosphere formation, proliferation, neurite outgrowth, and telomerase activity in cultured eNOS(-/-) SVZ neurospheres. SVZ explant cell migration also was significantly decreased in eNOS-/- mice compared with wild-type mice. These data indicate that eNOS is not only a downstream mediator for VEGF and angiogenesis but also regulates BDNF expression in the ischemic brain and influences progenitor cell proliferation, neuronal migration, and neurite outgrowth and affects functional recovery after stroke.
authors.affiliation: Department of Neurology, Henry Ford Health Sciences Center, Detroit, Michigan 48202, USA.
authors.forename: Jieli
authors.initials: J
authors.lastname: Chen
authors.forename: Alex
authors.initials: A
authors.lastname: Zacharek
authors.forename: Chunling
authors.initials: C
authors.lastname: Zhang
authors.forename: Hao
authors.initials: H
authors.lastname: Jiang
authors.forename: Yi
authors.initials: Y
authors.lastname: Li
authors.forename: Cynthia
authors.initials: C
authors.lastname: Roberts
authors.forename: Mei
authors.initials: M
authors.lastname: Lu
authors.forename: Alissa
authors.initials: A
authors.lastname: Kapke
authors.forename: Michael
authors.initials: M
authors.lastname: Chopp
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D001921:Brain / Q000473:pathology; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism*; D001973:Bromodeoxyuridine / Q000378:metabolism; D002452:Cell Count / Q000379:methods; D002465:Cell Movement / Q000235:genetics / Q000502:physiology; D049109:Cell Proliferation; D016510:Corneal Neovascularization; D004195:Disease Models, Animal; D000089622:Doublecortin Domain Proteins; D042783:Endothelial Cells / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology*; D007150:Immunohistochemistry / Q000379:methods; D020244:Infarction, Middle Cerebral Artery / Q000378:metabolism* / Q000503:physiopathology; D007381:Intermediate Filament Proteins / Q000378:metabolism; D019394:Ki-67 Antigen / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D009281:Naphthalenes; D009419:Nerve Tissue Proteins / Q000378:metabolism; D064231:Nestin; D016501:Neurites / Q000502:physiology; D009460:Neurologic Examination / Q000379:methods; D009479:Neuropeptides / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000172:deficiency / Q000494:pharmacology / Q000502:physiology*; D010082:Oxepins; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D020127:Recovery of Function / Q000235:genetics; D019098:Telomerase / Q000378:metabolism; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology
chemical_list: C461941:1-phenyl-1,4-epoxy-1H,4H-naphtho(1,8-de)(1,2)dioxepin; D019208:Brain-Derived Neurotrophic Factor; D000089622:Doublecortin Domain Proteins; D007381:Intermediate Filament Proteins; D019394:Ki-67 Antigen; D008869:Microtubule-Associated Proteins; D009281:Naphthalenes; D009419:Nerve Tissue Proteins; C577485:Nes protein, mouse; D064231:Nestin; D009479:Neuropeptides; D010082:Oxepins; D042461:Vascular Endothelial Growth Factor A; D052250:Nitric Oxide Synthase Type III; D019098:Telomerase; D001973:Bromodeoxyuridine
references.citation: J Mol Neurosci. 2000 Feb-Apr;14(1-2):3-15
references.pmid: 10854032
references.citation: Science. 2000 Feb 25;287(5457):1433-8
references.pmid: 10688783
references.citation: Circ Res. 2000 Sep 29;87(7):540-2
references.pmid: 11009557
references.citation: Neurobiol Dis. 2001 Feb;8(1):103-13
references.pmid: 11162244
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2604-9
references.pmid: 11226286
references.citation: J Neurooncol. 2000 Oct-Nov;50(1-2):139-48
references.pmid: 11245273
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4160-5
references.pmid: 11259645
references.citation: Stroke. 2001 Apr;32(4):1005-11
references.pmid: 11283404
references.citation: Acta Neuropathol. 2001 Mar;101(3):229-38
references.pmid: 11307622
references.citation: Neuroscience. 2001;105(1):33-41
references.pmid: 11483298
references.citation: Ann Neurol. 2001 Nov;50(5):602-11
references.pmid: 11706966
references.citation: Circ Res. 2002 Feb 22;90(3):284-8
references.pmid: 11861416
references.citation: Development. 2002 Mar;129(6):1435-42
references.pmid: 11880352
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3282-7
references.pmid: 11867712
references.citation: J Neurosci Methods. 2002 Mar 30;115(1):97-105
references.pmid: 11897369
references.citation: Neuromolecular Med. 2002;1(2):125-35
references.pmid: 12025858
references.citation: Oncogene. 2002 May 9;21(20):3130-8
references.pmid: 12082628
references.citation: Neuron. 2002 Jun 13;34(6):945-60
references.pmid: 12086642
references.citation: J Pathol. 2003 Jan;199(1):8-17
references.pmid: 12474221
references.citation: J Neurosci. 2002 Dec 15;22(24):10710-9
references.pmid: 12486164
references.citation: Brain Res. 2003 Feb 21;964(1):159-63
references.pmid: 12573525
references.citation: FEBS Lett. 2003 Feb 11;536(1-3):180-6
references.pmid: 12586360
references.citation: Ann Neurol. 2003 Jun;53(6):743-51
references.pmid: 12783420
references.citation: Dev Biol. 2003 Jun 15;258(2):319-33
references.pmid: 12798291
references.citation: Genes Brain Behav. 2002 Nov;1(4):204-13
references.pmid: 12882365
references.citation: J Neurosci. 2003 Jul 30;23(17):6856-65
references.pmid: 12890780
references.citation: Mol Cell Neurosci. 2003 Aug;23(4):693-702
references.pmid: 12932448
references.citation: J Neurosci. 2003 Oct 15;23(28):9357-66
references.pmid: 14561863
references.citation: Ann Neurol. 2003 Nov;54(5):582-90
references.pmid: 14595647
references.citation: Atheroscler Suppl. 2003 Dec;4(4):53-60
references.pmid: 14664903
references.citation: J Cell Biol. 2003 Dec 22;163(6):1375-84
references.pmid: 14691144
references.citation: Brain Res. 2004 Apr 16;1005(1-2):21-8
references.pmid: 15044060
references.citation: J Biomol Screen. 2004 Apr;9(3):232-43
references.pmid: 15146854
references.citation: Trends Mol Med. 2004 Apr;10(4):143-5
references.pmid: 15162796
references.citation: J Vet Med Sci. 2004 May;66(5):539-41
references.pmid: 15187365
references.citation: Eur J Neurosci. 2004 Aug;20(4):885-95
references.pmid: 15305857
references.citation: J Pharmacol Sci. 2004 Oct;96(2):208-18
references.pmid: 15492463
references.citation: Neurol Res. 1987 Dec;9(4):241-4
references.pmid: 2895900
references.citation: Exp Neurol. 1988 Dec;102(3):318-24
references.pmid: 3197789
references.citation: J Cereb Blood Flow Metab. 1990 Mar;10(2):290-3
references.pmid: 1689322
references.citation: Proc Natl Acad Sci U S A. 1994 May 10;91(10):4214-8
references.pmid: 7514300
references.citation: Neuron. 1994 Nov;13(5):1071-82
references.pmid: 7946346
references.citation: Science. 1996 Feb 16;271(5251):978-81
references.pmid: 8584933
references.citation: Dev Biol. 1996 Apr 10;175(1):1-13
references.pmid: 8608856
references.citation: J Comp Neurol. 2000 Oct 2;425(4):479-94
references.pmid: 10975875
references.citation: J Neurosci. 2000 Jan 1;20(1):283-93
references.pmid: 10627606
references.citation: Biochem Biophys Res Commun. 1999 Nov 30;265(3):636-9
references.pmid: 10600473
references.citation: Mol Cell Neurosci. 1999 Jun;13(6):450-64
references.pmid: 10383830
references.citation: Brain Res Mol Brain Res. 1999 Jan 8;63(2):366-70
references.pmid: 9878831
references.citation: J Cereb Blood Flow Metab. 1996 Sep;16(5):981-7
references.pmid: 8784243
references.citation: J Clin Invest. 1997 Jun 1;99(11):2625-34
references.pmid: 9169492
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14389-94
references.pmid: 9826710
references.citation: Amino Acids. 1998;14(1-3):121-9
references.pmid: 9871451
references.citation: Stroke. 1998 Sep;29(9):1972-80; discussion 1980-1
references.pmid: 9731626
references.citation: J Clin Invest. 1998 Jun 1;101(11):2567-78
references.pmid: 9616228
references.citation: Circ Res. 1998 May 18;82(9):1007-15
references.pmid: 9598598
references.citation: J Clin Invest. 1998 Feb 15;101(4):731-6
references.pmid: 9466966